Brad Dahms | CFO |
Carsten Brunn | President and CEO |
Dr. Peter G. Traber | Chief Medical Officer |
Takashi Kishimoto | Chief Scientific Officer |
Eliana Merle | Cantor Fitzgerald |
John Newman | Canaccord |
Raju Prasad | William Blair |
Ben Porter | Stifel |
Dan Clark | Mizuho |
Boobalan Pachaiyappan | H.C. Wainwright |
Good morning, and welcome to the Selecta Biosciences Second Quarter 2020 Financial Results and Corporate Update Conference Call. [Operator Instructions] This call is being webcast live on the Investors & Media section of Selecta's website at www.selectabio.com and it is being recorded.
For opening remarks, I would like to introduce you to Brad Dahms, Chief Financial Officer of Selecta. Please go ahead.
Thank you, operator, and good morning.